Eli Lilly's combination antibody therapy for COVID-19 cuts risk of hospitalization and death by 87%

The combination therapy from from Eli Lilly & Corecognizes the coronavirus and attaches to it, which blocks the pathogen from entering cells and spreading throughout the body.

from Health News | Mail Online https://ift.tt/3bEo2Nj